Share

January 2021; 8 (1) Clinical/Scientific NotesOpen Access

Tumefactive inflammatory lesions in juvenile metachromatic leukodystrophy

Kolja Meier, Jutta Gärtner, Peter Huppke
First published November 23, 2020, DOI: https://doi.org/10.1212/NXI.0000000000000922
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
485

Share

See original article:

Article Information

vol. 8 no. 1 e922
DOI: 
https://doi.org/10.1212/NXI.0000000000000922
PubMed: 
33229454
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received August 18, 2020
  • Accepted in final form October 12, 2020
  • First Published November 23, 2020.
Copyright & Usage: 
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Kolja Meier, MD,
    2. Jutta Gärtner, MD and
    3. Peter Huppke, MD
  1. Kolja Meier, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Jutta Gärtner, MD and
    3. Scientific Advisory Boards:

    1. scientific advisory board Novartis, Pediatric Multiple Sclerosis

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. travel and speaker honoraria from Bayer Vital, Biogen, Novartis and Sanofi

    Editorial Boards:

    1. Neuropediatrics, editorial board, since 2010Neuropadiatrie in Klinik und Praxis, editorial board, since 2005Monatsschrift Kinderheilkunde, editorial board, since 2005

    Patents:

    1. Drug for the treatment of Multiple Sulfatase Deficiency, US-Patents Nr. 16591051, 2019

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. research grant support from Novartis

    Research Support, Government Entities:

    1. research grant support fromDeutsche Forschungsgemeinschaft, GA354/14-1, since 2015Deutsche Forschungsgemeinschaft, GA354/15-1, since 2017Deutsche Forschungsgemeinschaft, EXC 2067/1, since 2019Deutsche Forschungsgemeinschaft, TRR 274/1, since 2020

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Peter Huppke, MD
    4. Scientific Advisory Boards:

    1. Bayer vital Merck Serono Novartis Alexion GW Pharmaciticals

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Bayer Health Care, Travel Serono, Travel Speaker honoraria from Bayer Health care, Novartis, Merck Serono

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. German Research foundation

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Pediatrics and Adolescent Medicine, Pediatric Neurology, University Medical Center Göttingen, Georg August University, Germany.
  1. Correspondence
    Dr. Huppke phuppke{at}med.uni-goettingen.de
View Full Text

Article usage

Article usage: November 2020 to April 2023

AbstractFullPdfSource
Nov 2020021729Highwire
Dec 2020146178Highwire
Jan 2021314438Highwire
Feb 202188112Highwire
Mar 20211015219Highwire
Apr 2021106012Highwire
May 202148011Highwire
Jun 20217298Highwire
Jul 202132211Highwire
Aug 20213275Highwire
Sep 20211289Highwire
Oct 202104224Highwire
Nov 202133716Highwire
Dec 202113417Highwire
Jan 202205528Highwire
Feb 202213112Highwire
Mar 202215518Highwire
Apr 202207215Highwire
May 202214213Highwire
Jun 20223268Highwire
Jul 20226327Highwire
Aug 20223345Highwire
Sep 202213312Highwire
Oct 202202715Highwire
Nov 202216518Highwire
Dec 202203510Highwire
Jan 202303010Highwire
Feb 202303211Highwire
Mar 20231296Highwire
Apr 20230208Highwire

Cited By...

Letters: Rapid online correspondence

Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles